Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Autolus Therapeutics plc American Depositary Share (AUTL)

Biological Products, (no Disgnostic Substances)

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

THE MEDIAWORKS, 191 WOOD LANE
LONDON, X0

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/22/2018

Market Cap

996,340,652

Shares Outstanding

173,990,000

Weighted SO

173,989,157

Total Employees

N/A

Upcoming Earnings

11/23/2018

Similar Tickers

CGEM --.--%

BOLT --.--%

DAWN --.--%

LYRA --.--%

ABOS --.--%

XFOR --.--%

INZY --.--%

VECT --.--%

TERN --.--%

Beta

2.1060

Last Div

0.0000

Range

2.01-7.45

Chg

-0.0050

Avg Vol

1286837

Mkt Cap

996340652

Exch

NASDAQ

Country

GB

Phone

44 20 3829 6230

DCF Diff

2.8288

DCF

0.9162

Div Yield

0.0000

P/S

81.1881

EV Multiple

-3.2715

P/FV

1.8874

Div Yield %

0.0000

P/E

-4.2579

PEG

-0.4766

Payout

0.0000

Current Ratio

18.5023

Quick Ratio

18.5023

Cash Ratio

17.2834

DSO

1102.1382

DIO

0.0000

Op Cycle

1102.1382

DPO

68.4141

CCC

1033.7241

Gross Margin

0.5227

Op Margin

-15.1881

Pretax Margin

-18.4581

Net Margin

-19.0663

Eff Tax Rate

-0.0330

ROA

-0.2741

ROE

-0.6676

ROCE

-0.2293

NI/EBT

1.0330

EBT/EBIT

1.2153

EBIT/Rev

-15.1881

Debt Ratio

0.2845

D/E

0.4602

LT Debt/Cap

0.3114

Total Debt/Cap

0.3151

Int Coverage

-4.2134

CF/Debt

-0.6448

Equity Multi

1.6172

Rec Turnover

0.3312

Pay Turnover

5.3352

Inv Turnover

0.0000

FA Turnover

0.1355

Asset Turnover

0.0144

OCF/Share

-0.5887

FCF/Share

-0.6051

Cash/Share

2.6575

OCF/Sales

-12.7622

FCF/OCF

1.0278

CF Coverage

-0.6448

ST Coverage

-37.0518

CapEx Coverage

-36.0124

Div&CapEx Cov

-36.0124

P/BV

1.8874

P/B

1.8874

P/S

81.1881

P/E

-4.2579

P/FCF

-6.1897

P/OCF

-6.3611

P/CF

-6.3611

PEG

-0.4766

P/S

81.1881

EV Multiple

-3.2715

P/FV

1.8874

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 10, 00:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024 Benzinga Dec 13, 15:00 Analyst Expectations for Autolus Therapeutics's Future GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 GlobeNewswire Inc. Dec 09, 20:30 Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023

Revenue Product Segmentation